WHO ICTRP trial
unani treatment of Kathra al-Bawl (Overactive Bladder) with Jawarish Kundur and…
CTRI/2023/03/050407 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/03/050407 |
|---|---|
| Public title | unani treatment of Kathra al-Bawl (Overactive Bladder) with Jawarish Kundur and Oxybutynin |
| Scientific title | A randomized, parallel group, open label, Standard controlled clinical study to Compare the efficacy and safety of unani Pharmacopoeial Formulation Jawarish Kundur with Oxybutynin in cases of Kathra al-Bawl (Overactive Bladder) |
| Primary sponsor | Central Council for research in Unani Medicine |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: N30-N39- Other diseases of the urinary system |
| Interventions | Intervention1: Jawarish Kundur: 5 gm BD administered orally with water twice daily for 6 weeks. Control Intervention1: Oxybutynin: 5 mg administered orally with water twice daily for 6 weeks |
| Registration date | Jun 3, 2023 |
| Target size | 105 |
| Secondary IDs | JK/OAB/AJ/Cl-NVAL/CCRUM 2020-2021 Version 03 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: